Who owns Bellerophon Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Bellerophon Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Bellerophon Therapeutics stock

Who bought or sold Bellerophon Therapeutics Inc this quarter?

There are no current stakeholders of Bellerophon Therapeutics.

This is normal when the security:

  • Has been acquired or taken private
  • Has merged with another entity
  • Has changed its name and has a new CUSIP (and/or symbol)
  • Has been delisted and the ticker has changed

Please use Search to find the security you were looking for.

Who sold out of Bellerophon Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Acadian Asset Management Sep 2023 383k $152k
BlackRock Sep 2023 128k $51k
Geode Capital Management Sep 2023 96k $38k
Northern Trust Sep 2023 30k $12k
Susquehanna International Sep 2023 15k $6.1k
Raymond James & Associates Dec 2023 10k $370.000000